Vanguard Group Inc. Has $1.83 Billion Stock Position in Tenet Healthcare Corporation $THC

Vanguard Group Inc. cut its stake in Tenet Healthcare Corporation (NYSE:THC) by 4.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,009,590 shares of the company’s stock after selling 452,814 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Tenet Healthcare worth $1,829,307,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. NewEdge Advisors LLC raised its position in Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after purchasing an additional 166 shares during the last quarter. Jones Financial Companies Lllp grew its stake in shares of Tenet Healthcare by 299.1% in the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after acquiring an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC purchased a new stake in shares of Tenet Healthcare during the second quarter worth $290,000. Chicago Partners Investment Group LLC bought a new stake in Tenet Healthcare in the second quarter valued at approximately $273,000. Finally, Stephens Inc. AR purchased a new position in shares of Tenet Healthcare during the 2nd quarter worth approximately $306,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.81% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have commented on THC shares. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 31st. Morgan Stanley reiterated an “overweight” rating and set a $260.00 price target on shares of Tenet Healthcare in a report on Thursday, February 12th. Guggenheim lifted their price objective on shares of Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a research report on Friday, February 13th. Barclays upped their price target on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and an average price target of $246.71.

Tenet Healthcare Trading Down 1.8%

Shares of THC opened at $227.68 on Friday. The company has a market capitalization of $19.80 billion, a PE ratio of 14.70, a price-to-earnings-growth ratio of 1.14 and a beta of 1.44. The stock has a fifty day moving average of $201.26 and a two-hundred day moving average of $196.69. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $235.77.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same quarter in the previous year, the firm earned $3.44 earnings per share. The business’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts forecast that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.